Schizophrenia/Psychosis

 

Cognition and Outcomes in Clinical High-Risk for Psychosis

September 16, 2020

Does cognition predict outcomes in patients at clinical high-risk for psychosis?

Anti-NMDA Receptor Encephalitis With Visual Hallucinations and Cognitive Impairment

September 15, 2020

In comparison to the classic presentation of schizophrenia, ANMDARE features a later age of onset, female predominance, visual hallucinations, relative lack of cognitive disorganization, and a lack of an extended prodromal period.

What's In Your Mouth?

September 14, 2020

The role of the oropharyngeal microbiome in schizophrenia and mania.

Delirium, Encephalopathy, and COVID-19: An Update From the Field

September 08, 2020

The biggest challenge we have faced thus far has been a three-fold rise in requests for assistance in managing persistent delirium. Needless to say, we are not twiddling our thumbs.

Combination Therapy for Treatment-Resistant Schizophrenia?

September 04, 2020

New research on the role of adjunctive long-acting injectable antipsychotics in treatment-resistant schizophrenia.

Schizophrenia: Clinical Considerations in Men Versus Women

August 27, 2020

A nationwide cohort study sought to determine the clinical course of schizophrenia in women and men in order to improve diagnostic accuracy and design guidelines.

To Scan or Not to Scan: Brain Imaging in First-Episode Psychosis

August 25, 2020

The role of neuroimaging is to rule out medically or surgically treatable causes of illness, such as new-onset psychosis.

A Double Whammy: Psychosis and Huntington Disease

August 18, 2020

When the patient has significant comorbid psychiatric problems, high risk of suicide, and Huntington disease, the role of clinician spills over into patient advocate in a complex medical system.

5 Diagnostic Tests for Autoimmune Encephalitis

August 04, 2020

With adequate clinician awareness and prompt initiation of diagnostic testing and intervention, patients with autoimmune encephalitis can lead productive lives. A range of tests is described here.

Key Concepts About Polypharmacy in Psychotic Disorders

August 03, 2020

Clinicians should keep in mind the risk-to-benefit ratio considerations before initiating polypharmacy, especially if they have patients with prescriptions inherited from several sources. Here: A summary of recommendations about the use of polypharmacy in psychotic disorders.